Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | TST003 |
| Synonyms | |
| Therapy Description |
TST003 is a monoclonal antibody that targets Gremlin-1 (GREM1), potentially leading to inhibition of tumor growth (Cancer Res (2023) 83 (7_Supplement): 465). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| TST003 | TST-003|TST 003 | TST003 is a monoclonal antibody that targets Gremlin-1 (GREM1), potentially leading to inhibition of tumor growth (Cancer Res (2023) 83 (7_Supplement): 465). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05731271 | Phase Ib/II | TST003 | A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors | Active, not recruiting | USA | 0 |